The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Open accessAbstract
Background & aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical phenotypes in a large international cohort of patients with PSC.Methods We performed a retrospective outcome analysis of patients diagnosed with PSC from 1980 through 2010 at 37 centers in Europe, North America, and Australia. For each patient, we collected data on sex, clinician-reported age at and date of PSC and IBD diagnoses, phenotypes of IBD and PSC, and date and indication of IBD-related surgeries. The primary and secondary endpoints were liver transplantation or death (LTD) and hepatopancreatobiliary malignancy, respectively. Cox proportional hazards models were applied to determine the effects of individual covariates on rates of clinical events, with time-to-event analysis ascertained through Kaplan-Meier estimates.Results Of the 7121 patients in the cohort, 2616 met the primary endpoint (median time to event of 14.5 years) and 721 developed hepatopancreatobiliary malignancy. The most common malignancy was cholangiocarcinoma (n = 594); patients of advanced age at diagnosis had an increased incidence compared with younger patients (incidence rate: 1.2 per 100 patient-years for patients younger than 20 years old, 6.0 per 100 patient-years for patients 21-30 years old, 9.0 per 100 patient-years for patients 31-40 years old, 14.0 per 100 patient-years for patients 41-50 years old, 15.2 per 100 patient-years for patients 51-60 years old, and 21.0 per 100 patient-years for patients older than 60 years). Of all patients with PSC studied, 65.5% were men, 89.8% had classical or large-duct disease, and 70.0% developed IBD at some point. Assessing the development of IBD as a time-dependent covariate, Crohn's disease and no IBD (both vs ulcerative colitis) were associated with a lower risk of LTD (unadjusted hazard ratio [HR], 0.62; P < .001 and HR, 0.90; P = .03, respectively) and malignancy (HR, 0.68; P = .008 and HR, 0.77; P = .004, respectively). Small-duct PSC was associated with a lower risk of LTD or malignancy compared with classic PSC (HR, 0.30 and HR, 0.15, respectively; both P < .001). Female sex was also associated with a lower risk of LTD or malignancy (HR, 0.88; P = .002 and HR, 0.68; P < .001, respectively). In multivariable analyses assessing the primary endpoint, small-duct PSC characterized a low-risk phenotype in both sexes (adjusted HR for men, 0.23; P < .001 and adjusted HR for women, 0.48; P = .003). Conversely, patients with ulcerative colitis had an increased risk of liver disease progression compared with patients with Crohn's disease (HR, 1.56; P < .001) or no IBD (HR, 1.15; P = .002).Conclusions In an analysis of data from individual patients with PSC worldwide, we found significant variation in clinical course associated with age at diagnosis, sex, and ductal and IBD subtypes. The survival estimates provided might be used to estimate risk levels for patients with PSC and select patients for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The close relationship with IBD is likely relevant, as shown by variable disease behaviour depending on the clinical presentation of IBD.6,8”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“An important feature of PSC is the inherent risk of neoplasia at the affected mucosal surfaces, most commonly in the form of cholangiocarcinoma (CCA) and colorectal cancer.[5][6][7]”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“CCA is very rarely seen in patients with small duct PSC.6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“most people with PSC have benign strictures leading to end-stage disease and will not develop hepatobiliary malignancy.6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“Data supporting that IBD (and its inflammatory activity) is important for PSC progression is that UC, as opposed to no IBD 368 or Crohns disease, is associated with faster PSC progression.6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“In a large, multicentre international retrospective study including 781 children and young people diagnosed with PSC, 67% fulfilled the diagnostic criteria for AIH, in contrast to 6.6% in a similar study including 7,121 adults, suggesting higher prevalence in the paediatric population.6,427”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“In the retrospective outcome analysis of patients diagnosed with PSC from 1980 through 2010 at 37 centres in Europe, North America, and Australia including 7,121 patients, the incidence of CCA in 940 patients < -20 years-old was 1.2/100 patient-years increasing with age to 21/100 patientyears for those over the age of 60. 6”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
In the citing paper
“Patients with associated UC were at higher risk of developing CCA.”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling.
David, F. N., Olkin, I., Ghurye, S. G., Hoeffding, W., Madow, W. G., & Mann, H. B. (1961) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2984135 · Cited by 1,914
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Assche, G. V., Dignass, A. U., Panés, J., Beaugerie, L., Karagiannis, J. A., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E. J., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,444
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,230
Self-citationDignass, A. U., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G. J., Reinisch, W., Colombel, J., Vermeire, S., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.09.003 · Cited by 903
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
Self-citationHigh-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Self-citationHepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Self-citationThirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.035 · Cited by 645
Flagged first, then by citations
Research works printed but not linked: 6
- Boberg, 2002, Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation, Scand J Gastroenterol, 37, 1205, 10.1080/003655202760373434 · DOI
- Fevery, 2016, Patients with large-duct primary sclerosing cholangitis and Crohn’s disease have a better outcome than those with ulcerative colitis, or without IBD, Aliment Pharmacol Ther, 43, 612, 10.1111/apt.13516 · DOI · Paper page
- Rudolph, 2010, In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival, J Hepatol, 53, 313, 10.1016/j.jhep.2010.02.030 · DOI
- Boonstra, 2013, Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis, Hepatology, 58, 2045, 10.1002/hep.26565 · DOI · Paper page
- Bergquist, 2002, Hepatic and extrahepatic malignancies in primary sclerosing cholangitis, J Hepatol, 36, 321, 10.1016/S0168-8278(01)00288-4 · DOI · Paper page
- Lindor, 2009, High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis, Hepatology, 50, 808, 10.1002/hep.23082 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 534
Zhou, T., Fronhoffs, F., Kristiansen, G., Dold, L., Kaczmarek, D. J., Strassburg, C. P., & Weismüller, T. J. (2024) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13295 · Cited by 1
Self-citationPrimary sclerosing cholangitis and IgG4-associated cholangitis
Bowlus, C. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00020-5 · Cited by 1
Self-citationKalthoff, S., Wolniak, C., Lutz, P. L., Strassburg, C. P., Langhans, B., & Dold, L. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03343-3 · Cited by 1
Self-citationCucinotta, U., Dipasquale, V., Mayer, C., Alibrandi, A., Pigneur, B., Avril, S., Bergamo, C., Morello, R., Rümmele, F. M., Romano, C., et al. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.03.021 · Cited by 1
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis
Tatscher, E., Mady, S., & Fickert, P. (2025) · Seminars in Liver Disease · doi:10.1055/a-2601-9426 · Cited by 1
D’Amico, F., Allocca, M., Lusetti, F., Parigi, T. L., Rusconi, F., Hernández, G., Segovia‐Hilara, A., Solitano, V., Zilli, A., Furfaro, F., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70058 · Cited by 1
Self-citationManagement of Inflammatory Bowel Disease with History of Cancer
Annese, V., Parisi, M., Cinque, S., Cappellini, A., Biamonte, P., Dell’Anna, G., Testoni, S. G. G., & Annunziata, M. L. (2025) · Cancers · doi:10.3390/cancers17213475 · Cited by 1
Rojas-Amaris, N., Marenco‐Flores, A., Lara, C., Barba, R., Rubio-Cruz, D., Parraga, X., Goyes, D., Medina‐Morales, E., Sierra, L., Romero‐Gómez, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228083 · Cited by 1
Nakagawa, A., Alt, K. N. V., Mino-Kenudson, M. A., Adams, C. E., Purschke, B., Taniue, K., Thayer, S. P., Lillemoe, K. D., Bardeesy, N. M., Castillo, C. F. F.-D., et al. (2025) · FEBS Journal · doi:10.1111/febs.70330 · Cited by 1
Primary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges
Giorgio, S. S. D., Scandavini, C. M., Molinaro, A., Arnelo, U., & Valente, R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031149 · Cited by 2
Chen, Y., Wang, Z., Zeng, Y., Xie, X., Liu, L., & Qian, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1708826 · Cited by 3
Quality of Life in Patients With Primary Sclerosing Cholangitis
Møller, E. E., Gantzel, R. H., Herting, E. C., Mellemkjær, A., Bossen, L., Böttcher, M. H., Jørgensen, S. P., Møller, H. J., & Grønbæk, H. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100964 · Cited by 1
Liu, L., Liu, W., Shi, Y., Cha, X., Yin, P., Guan, Q., Fan, X., & Wang, M. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00923-8 · Cited by 1
Primary Sclerosing Cholangitis
Hussain, N., & Trivedi, P. J. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2026.04.013 · Cited by 1
Self-citationPredicting Prognosis in Primary Sclerosing Cholangitis: Conventional to Functional MRI
Thompson, C. P., Aswani, Y., Jayasekera, C. R., Carey, E. J., Silva, A. N., Panda, A., Venkatesh, S. K., Silva, A. C., & Sandrasegaran, K. (2026) · Radiographics · doi:10.1148/rg.260030 · Cited by 1
Primary Sclerosing Cholangitis Overlapping with IBD
Sabino, J., tenHove, J., & Torres, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_16 · Cited by 1
[Apolipoprotein B and small, dense LDL-C].
Ito, Y. (2012) · PubMed · Cited by 1
Costrini, N. V. (2022) · Gastro - Open Journal · doi:10.17140/goj-5-133 · Cited by 1
Kim, W. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-0120-1_14 · Cited by 2
Prognostic Models of Primary Sclerosing Cholangitis
Dolgushina, A. I., Selyanina, A. A., Dubrovina, V. V., Isyangildina, G. A., & Olevskaya, E. R. (2023) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-5-43-50 · Cited by 1
Setting up an integrated service for PSC-IBD patients: A quality improvement project
Kotha, S., Koumoutsos, I., Warner, B. D., Theocharidou, E., Mawdsley, J. E. D., & Berry, P. (2024) · iLiver · doi:10.1016/j.iliver.2024.100076 · Cited by 1
Adamowicz, M., Abramczyk, J., Kilańczyk, E., Milkiewicz, P., Łaba, A., Milkiewicz, M., & Kempińska‐Podhorodecka, A. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01033-y · Cited by 1
Self-citationPrimary sclerosing cholangitis
Ahmad, J., & Grewal, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00019-5 · Cited by 1
Primary Sclerosing Cholangitis
Sangha, S., & Bowlus, C. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-285-8_56 · Cited by 1
Self-citationShould we set-up routine screening for primary sclerosing cholangitis in all IBD patients?
Bouguen, G., Sparrow, M., & Roblin, X. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.07.043 · Cited by 1
Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis
Zhang, C. C., Voitl, R., Hippchen, T., Weiss, K.-H., Sauer, P., & Rupp, C. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1755357 · Cited by 1
Self-citationGeoepidemiology of Autoimmune Liver Diseases
Lyu, Z., Gershwin, M. E., & Ma, X. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_11 · Cited by 1
The role of gut microbiota in chronic liver diseases
Brillanti, S., & Alterini, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00003-6 · Cited by 1
Koistinen, H. K., Boyd, S., Arola, J., Jokelainen, K., Koistinen, R., Lempiäinen, A., Hotakainen, K., Stenman, U., & Färkkilä, M. A. (2021) · Livers · doi:10.3390/livers1040025 · Cited by 2
Self-citationPrimary Sclerosing Cholangitis
Bowlus, C. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_25 · Cited by 1
Self-citationPrimary sclerosing cholangitis
Lynch, K. D., & Chapman, R. W. (2020) · doi:10.1093/med/9780198746690.003.0326 · Cited by 1
Self-citationSurrogate Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC)
(2017) · Internal Medicine Research – Open Journal · doi:10.31038/imroj.2017231 · Cited by 1
Autoimmune Lebererkrankungen – ein Update (Teil 2)
Schregel, I., Steinmann, S., & Schramm, C. (2022) · Gastroenterologie up2date · doi:10.1055/a-1922-9264 · Cited by 1
Self-citationMomtazmanesh, S., Gholami, M., Pak, N., Sima, A. R., Montazeri, S. A., Kolahdoozan, S., Vahedi, H., & Radmard, A. R. (2022) · Polish Journal of Radiology · doi:10.5114/pjr.2022.121443 · Cited by 1
Predictors of the Clinical Course of Primary Sclerosing Cholangitis
Kalaitzakis, E., & Bjornsson, E. S. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.026 · Cited by 1
Weinberg, E. M., & Reddy, K. R. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14896 · Cited by 1
The Role of Extrahepatic Autoimmunity in Autoimmune Liver Disease
Wunsch, E., & Milkiewicz, P. (2020) · doi:10.1002/9781119532637.ch16 · Cited by 1
Self-citationEndoscopic Management of Primary Sclerosing Cholangitis
Das, R. K., Singh, H., & Slivka, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-56993-8_80 · Cited by 1
He, S., Peng, Y., & Wei, Q. (2023) · Hepatology · doi:10.1097/hep.0000000000000685 · Cited by 1
Primary sclerosing cholangitis: best practices for diagnosis
Bjornsson, E. S. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1358163
Bechstein, W. O., & Schnitzbauer, A. A. (2018) · Transplant International · doi:10.1111/tri.13158
Primär sklerosierende Cholangitis
Weismüller, T. J., & Strassburg, C. P. (2018) · Die Gastroenterologie · doi:10.1007/s11377-018-0250-0
Self-citation篤, 田. (2018) · 胆道 · doi:10.11210/tando.32.241
Kempińska‐Podhorodecka, A., Blatkiewicz, M., Wunsch, E., Krupa, Ł., Gutkowski, K., Milkiewicz, P., & Milkiewicz, M. (2018) · Preprints.org · doi:10.20944/preprints201807.0247.v1
Self-citationCirrhosis and Autoimmune Liver Disease
Stirnimann, G., Ebadi, M., Mason, A. L., & Montaño‐Loza, A. J. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00449-1
Self-citationVerbesserte Prognose, aber limitierte Therapieoptionen für PBC und PSC
Koenen, M. T., Zimmermann, H. W., & Trautwein, C. (2019) · Gastro-News · doi:10.1007/s15036-019-0633-1
Primary Sclerosing Cholangitis (PSC) in Children
Więcek, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90714
Chirurgische Therapie der primär sklerosierenden Cholangitis
Branchi, V., Weismüller, T. J., Zhou, T., Henn, J., Semaan, A., Glowka, T. R., Gonzalez-Carmona, M. A., Strassburg, C. P., Kalff, J. C., Manekeller, S., et al. (2020) · Der Chirurg · doi:10.1007/s00104-020-01197-5
Self-citationPrimär sklerosierende Cholangitis
Hoffmann, J. (2020) · Springer eBooks · doi:10.1007/978-3-662-59104-8_33
Dalekos, G. N., & Gatselis, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_23
Self-citationHepatobiliary Pathology in Paediatric Inflammatory Bowel Disease
Ricciuto, A. (2019) · TSpace (University of Toronto)
Endoscopic Management of Primary Sclerosing Cholangitis
Das, R. K., Singh, H., & Slivka, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-29964-4_80-1
Sclerosing Cholangitis in Children
Balistreri, W. F., & Lam, S. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108918978.021
Transplant and Autoimmune Diseases
Gambato, M., & Russo, F. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-65908-0_16
Ali, A. H., & Carey, E. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-70936-5_20
Risk Factors for Pancreatic Cancer and Cholangiocarcinoma
Hamada, T., & Nakai, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-2870-2_1
Samyn, M., Hensel, K. O., Hadžić, N., & Mieli‐Vergani, G. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.09.011
Matthaei, H., & Kalff, J. C. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-24812-2.00018-4
Primary Sclerosing Cholangitis
Schäfer, C., & Albert, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-42569-2_45
Primär sklerosierende Cholangitis
Weismüller, T. J. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23847-5.00053-3
Self-citationHohenester, S. D., & Denk, G. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.65701-x
Adult Cholestatic and Biliary Tract Diseases
(2022) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477183-7
Geschlechtsspezifische Unterschiede in gastroenterologischen Erkrankungen
Roth, L., Michl, P., & Rosendahl, J. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01491-4
Przybyszewski, E. M., & Pratt, D. S. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000020
Diversitätsfaktoren in der Gastroenterologie
Hof, T., Thimme, R., & Hasselblatt, P. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1892-4878
Primary sclerosing cholangitis
Nayagam, J. S., & Joshi, D. (2023) · Medicine · doi:10.1016/j.mpmed.2023.03.016
Burghart, L. (2023) · rheuma plus · doi:10.1007/s12688-023-00628-5
Lakkasani, S., Jagirdhar, G. S. K., Qirem, M., Digiacomo, S. W., & Pantula, S. (2023) · Cureus · doi:10.7759/cureus.43403
Ito, A., Murasugi, S., Yonezawa, M., Omori, T., Nakamura, S., & Tokushige, K. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22099
Inflammatory Bowel Disease: Extraintestinal Manifestations and Colorectal Cancer
Quinn, K. P., & Raffals, L. E. (2024) · doi:10.1093/med/9780197679753.003.0017
The morphomolecular features of cholangiocarcinoma in the personalised era
Field, D. T., Carpino, G., Doukas, M., & Kendall, T. J. (2024) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2024.01.004
Role of PAR1 −506 deletion/insertion polymorphism in primary sclerosing cholangitis
Langhans, B., Kalthoff, S., Zhou, T., Weismüller, T. J., Lenzen, H., Nischalke, H. D., Strassburg, C. P., Lutz, P. L., & Dold, L. (2024) · Hepatology Research · doi:10.1111/hepr.14035
Self-citationPrimär sklerosierende Cholangitis
Weismüller, T. J. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21005-1.00056-1
Self-citationIt’s Not Always Infections When It Comes to Resource-Poor Countries: A Fascinating Case Report
Swaminathan, G., Sethi, A. K., PATRIZI, S., Elhawary, A., Al-Howthi, N., Saha, U., & Defillo-Lopez, C. (2024) · Cureus · doi:10.7759/cureus.66469
Tearle, J. L. E., Zhang, F., Jackson, K., Malhotra, P., Tavakoli, P., Koentgen, S., Warren, J., Williams, C., Haque, A., Arzivian, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.12.607536
Overlap syndrome in liver diseases in children: case report and literature review
Васильевна, В. Г., Андреевна, С. Т., Nikitin, A. V., Хавкин, А. И., Khasanova, K. A., Сергеевна, К. Е., & Skоbееv, D. А. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-226-6-155-162
High-Grade Stricture in Primary Sclerosing Cholangitis
Harisinghani, M. G., Dhami, R., Karbhari, A., Goyal, R., Ghosh, S., Nakrour, N., Majeed, F., Consul, N., Azimi, N., Cheng, M., et al. (2024) · Springer eBooks · doi:10.1007/978-3-031-68233-9_47
Uździcki, A. W., & Wawrzynowicz‐Syczewska, M. (2024) · Gastroenterology Review · doi:10.5114/pg.2024.145575
Wunsch, E., Milkiewicz, M., Norman, G. L., Łaba, A., Kruk, B., & Milkiewicz, P. (2025) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16910
Self-citationEinsatz von künstlicher Intelligenz in der biliären Diagnostik
Albert, A., Dobsch, P., Ziegler, J., Hofstetter, P., Heumann, P., Müller-Schilling, M., & Kandulski, A. (2025) · Die Gastroenterologie · doi:10.1007/s11377-024-00848-x
Progress in Liver Cancer Associated to Autoimmune Liver Disease
Wang, D., Song, L., Guan, L., Lu, Y., & Han, Y. (2025) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2025.07(02).20
Espanov, A. A. (2025) · Diagnostic radiology and radiotherapy · doi:10.22328/2079-5343-2025-16-1-47-56
Annese, V., & Sociale, O. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-87503-8_25
Prevalence of liver disease around the world
Cortez‐Pinto, H., Craciun, A., Crespo, R. R., & Carvalhana, S. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00001-0
Colangitis esclerosante primaria: caracterización de una cohorte en un hospital universitario
Cuadrado-Cárdenas, V., Gómez, J. R. M., & Maya, O. G. M. (2025) · Hepatología · doi:10.59093/27112330.146
Nishad, N., Niriella, M. A., Silva, A. P. D., Butler, K., Subramanian, S., & Thoufeeq, M. (2025) · Current Hepatology Reports · doi:10.1007/s11901-025-00705-7
Zheng, Q.-K., Shi, Y.-N., Zhu, B.-Y., Sun, K., Mei, B.-Y., Feng, S.-M., & Niu, H. (2025) · Research Square · doi:10.21203/rs.3.rs-7839914/v1
Middelburg, T. E., Mol, B., Ferreira, C., Davis, T., Horsthuis, K., de Boer, Y. S., van der Meer, A. J., de Vries, A. C., Dwarkasing, R. S., Bogaards, J. A., et al. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.103417
Self-citationKalthoff, S., Wolniak, C., Lutz, P., Strassburg, C. P., Langhans, B., & Dold, L. (2024) · Figshare · doi:10.6084/m9.figshare.26500355
Self-citationAli, A. H., Juran, B. D., Schlicht, E. M., Bianchi, J. K., McCauley, B. M., Atkinson, E. J., & Lazaridis, K. N. (2021) · Figshare · doi:10.6084/m9.figshare.16681615
Self-citationDong, X., Gong, L.-L., Hong, M.-Z., & Pan, J.-S. (2024) · Figshare · doi:10.6084/m9.figshare.25248769
Marcus, E., Stone, P. C., Thorburn, D., Walmsley, M., & Vivat, B. (2022) · Figshare · doi:10.6084/m9.figshare.20329452
Self-citationAdditional file 1 of Quality of life in primary sclerosing cholangitis: a systematic review
Marcus, E., Stone, P., Krooupa, A.-M., Thorburn, D., & Vivat, B. (2021) · Figshare · doi:10.6084/m9.figshare.14253837
Self-citationAutoimmune Hepatitis and Overlapping Syndrome
Liang, Y., & Zhang, X. (2025) · Pracatical anatomic pathology · doi:10.1007/978-3-031-97506-6_11
Risk factors and clinical presentation of biliary tract cancers
Rezaee-Zavareh, M. S., & Yang, J. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29287-3.00016-7
Differenzialdiagnostik der Cholestase bei Erwachsenen
Dröge, C., Berg, T., & Keitel-Anselmino, V. (2025) · Gastroenterologie up2date · doi:10.1055/a-2333-8987
Cornillet, M., Båve, A. L., Sun, D., Nouaïria, G., Villard, C., Grigoriadis, A., von Seth, E., Jansson, H., Álvez, M. B., Bergström, S., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101719
Self-citationMalik, U. E., Ashraf, B., Samuel, S. B., & Hasak, S. (2025) · Clinical gastroenterology · doi:10.1007/978-3-032-07868-1_12
Auf Du und Du mit dem Gallen- und Pankreasgang
Trung, K. V., Hoffmeister, A., & Kandulski, A. (2026) · Die Innere Medizin · doi:10.1007/s00108-025-02043-8
Metadata
- Authors
- Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., Thorburn, D., Weersma, R. K., Fevery, J., Mueller, T., Chazouillères, O., Schulze, K., Lazaridis, K. N., Almer, S., Pereira, S. P., Levy, C., Mason, A., Naess, S., Bowlus, C. L., Floreani, A., Halilbasic, E., Yimam, K. K., Milkiewicz, P., Beuers, U., Huynh, D. K., Pares, A., Manser, C. N., Dalekos, G. N., Eksteen, B., Invernizzi, P., Berg, C. P., Kirchner, G. I., Sarrazin, C., Zimmer, V., Fabris, L., Braun, F., Marzioni, M., Juran, B. D., Said, K., Rupp, C., Jokelainen, K., Benito de Valle, M., Saffioti, F., Cheung, A., Trauner, M., Schramm, C., Chapman, R. W., Karlsen, T. H., Schrumpf, E., Strassburg, C. P., Manns, M. P., Lindor, K. D., Hirschfield, G. M., Hansen, B. E., & Boberg, K. M.
- Affiliations
- University of Bonn (DE)
- Queen Elizabeth Hospital Birmingham (GB)
- Karolinska University Hospital (SE)
- Mayo Clinic (US)
- Medizinische Hochschule Hannover (DE)
- Amsterdam UMC Location University of Amsterdam (NL)
- Oslo University Hospital (NO)
- University Hospital Heidelberg (DE)
- University of Helsinki (FI)
- University of Gothenburg (SE)
- The Royal Free Hospital (GB)
- University Medical Center Groningen (NL)
- Universitair Ziekenhuis Leuven (BE)
- Charité – Universitätsmedizin Berlin (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Medical Center Hamburg-Eppendorf (DE)
- Linköping University (SE)
- University College London (GB)
- University of Miami (US)
- University of Alberta (CA)
- University of California, Davis (US)
- University of Padua (IT)
- Medical University of Vienna (AT)
- California Pacific Medical Center (US)
- Medical University of Warsaw (PL)
- Royal Adelaide Hospital (AU)
- University Hospital Zurich (CH)
- University of Calgary (CA)
- University of Milan (IT)
- University of Tübingen (DE)
- University Hospital Regensburg (DE)
- Goethe University Frankfurt (DE)
- Universitätsklinikum des Saarlandes (DE)
- University Hospital Schleswig-Holstein (DE)
- Marche Polytechnic University (IT)
- John Radcliffe Hospital (GB)
- National Institute for Health and Care Research (GB)
- University of Toronto (CA)
- Corresponding author
- Weismüller, Tobias J.
- Boberg, Kirsten M.
- ORCID
- Weismüller, Tobias J.
- Trivedi, Palak J.
- Bergquist, Annika
- Imam, Mohamad
- Lenzen, Henrike
- Ponsioen, Cyriel Y.
- Holm, Kristian
- Gotthardt, Daniel
- Färkkilä, Martti A.
- Marschall, Hanns-Ulrich
- Thorburn, Douglas
- Weersma, Rinse K.
- Fevery, Johan
- Mueller, Tobias
- Chazouillères, Olivier
- Schulze, Kornelius
- Lazaridis, Konstantinos N.
- Almer, Sven
- Pereira, Stephen P.
- Levy, Cynthia
- Mason, Andrew
- Bowlus, Christopher L.
- Floreani, Annarosa
- Halilbasic, Emina
- Milkiewicz, Piotr
- Beuers, Ulrich
- Eksteen, Bertus
- Invernizzi, Pietro
- Berg, Christoph P.
- Zimmer, Vincent
- Fabris, Luca
- Braun, Felix
- Marzioni, Marco
- Said, Karouk
- Rupp, Christian
- Saffioti, Francesca
- Cheung, Angela
- Trauner, Michael
- Schramm, Christoph
- Chapman, Roger W.
- Karlsen, Tom H.
- Strassburg, Christian P.
- Manns, Michael P.
- Lindor, Keith D.
- Hirschfield, Gideon M.
- Hansen, Bettina E.
- Boberg, Kirsten M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 152
- Issue
- 8
- Pages
- 1975-1984.e8
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC5546611
- OpenAlex
- W2594589478
- Cited by
- 533
- References
- 74
- Citations by year
- 2026: 49 · 2025: 58 · 2024: 60 · 2023: 65 · 2022: 59 · 2021: 68 · 2020: 55 · 2019: 43 · 2018: 49 · 2017: 24
- FWCI
- 28.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc-nd)
- UCL Discovery (University College London) (submittedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Wellcome Trust
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK084960)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, inflammatory bowel disease, cholangiocarcinoma, liver transplantation, disease progression, age at diagnosis, sex differences, Crohn's disease, ulcerative colitis, IBD surgery, mortality
- MeSH terms
- Adult, Australia, Colitis, Ulcerative, Crohn Disease, Europe, Female, Humans, Male, Middle Aged, North America, Phenotype, Prognosis, Retrospective Studies, Risk Factors, Time Factors, Cholangitis, Sclerosing, Incidence, Multivariate Analysis, Chi-Square Distribution, Proportional Hazards Models, Liver Transplantation, Age Distribution, Sex Distribution, Disease Progression, Risk Assessment, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
